We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CPIX market cap is 23.52M. The company's latest EPS is USD -0.4405 and P/E is -3.63.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 11.41M | 9.12M | 9.23M | 10.89M | 10.09M |
Operating Income | -288k | -2.28M | -1.53M | 22k | -1.87M |
Net Income | -409k | -2.44M | 192k | 872k | -1.05M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 47.53M | 37.44M | 35.99M | 42.01M | 39.55M |
Operating Income | -3.62M | -6.38M | -7.68M | -5.71M | -9.56M |
Net Income | -3.54M | -3.34M | -3.51M | -5.57M | -6.28M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 90.78M | 92.93M | 89.47M | 89.38M | 87.75M |
Total Liabilities | 52.29M | 56.95M | 53.42M | 52.54M | 52.1M |
Total Equity | 38.49M | 35.97M | 36.05M | 36.84M | 35.66M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 104.55M | 96.46M | 84.46M | 92.93M | 81.78M |
Total Liabilities | 53.46M | 49.59M | 41.86M | 56.95M | 52.52M |
Total Equity | 51.09M | 46.87M | 42.6M | 35.97M | 29.26M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 4.82M | 8.45M | -1.42M | 3.82M | 5.05M |
Investing | -13.03M | -13.67M | -175k | -271k | -367k |
Financing | 719k | -2.06M | -1.78M | -5.06M | -5.94M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 3.06M | 5.42M | 6.34M | 8.45M | 6.09M |
Investing | 2.3M | -1.76M | -502k | -13.67M | -106k |
Financing | -5.08M | -7.12M | -3.55M | -2.06M | -7.42M |
Market Cap | 23.52M |
Price to Earnings Ratio | -3.63 |
Price to Sales Ratio | 0.58 |
Price to Cash Ratio | 1.24 |
Price to Book Ratio | 0.78 |
Dividend Yield | - |
Shares Outstanding | 14.26M |
Average Volume (1 week) | 4.3k |
Average Volume (1 Month) | 9.08k |
52 Week Change | -14.06% |
52 Week High | 2.3587 |
52 Week Low | 1.43 |
Spread (Intraday) | 0.15 (8.77%) |
Company Name | Cumberland Pharmaceutical Inc |
Address |
2525 west end avenue nashville, tennessee 37203 |
Website | https://www.cumberlandpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions